© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription. Fisher & Paykel Healthcare has initiated a ...
Fisher & Paykel Healthcare’s new Airvo™ 3 device with OptiO2™ technology, with support from Medical Research Institute of New Zealand, offers a major breakthrough in the delivery of oxygen therapy to ...
The Department of Health (DoH) has issued a warning to staff following reports that a number of life-saving breathing devices had malfunctioned during use. A Northern Ireland Safety Notice posted to ...
We maintain our NZD 23.50 fair value estimate for narrow-moat Fisher & Paykel Healthcare, or AUD 22.00 at current exchange rates, following the firm initiating a voluntary limited recall of Airvo 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results